PMID: 9542328May 16, 1998Paper

Waldenström's macroglobulinemia complicated with acute myeloid leukemia. Report of a case and review of the literature

Haematologica
J N RodríguezD Prados

Abstract

The evolution of Waldenström's macroglobulinemia (WM) into chronic or acute myeloid leukemia (AML) is a rare event. Most of these cases have occurred after treatment with alkylating agents. We herein report a case of WM terminating in an acute myelomonocytic leukemia after treatment with prednimustine and chlorambucil and present a review of the literature.

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M A DimopoulosS P Treon
JPMA. the Journal of the Pakistan Medical Association
Safoorah KhalidMohammad Khurshid
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
S P TreonAshraf Badros
© 2022 Meta ULC. All rights reserved